Moxidectin has been approved for onchocerciasis. What advantage does it offer over ivermectin?...

Question

Moxidectin has been approved for onchocerciasis. What advantage does it offer over ivermectin?

Accepted Answer

Longer duration of microfilarial suppression (12-18 months vs 3-6 months) due to its longer half-life, potentially allowing less frequent dosing

Answer

It is a macrofilaricide

Answer

No side effects

Answer

Cheaper than ivermectin

Answer

Treats all helminths

uk-dtmh MCQ (SBA): Moxidectin vs Ivermectin